We also stained the tumor of nude mice transplanted with HepG2 cell line after treatment, and determined that FOXM1-PROTAC can also inhibit the expression of GLUT1 and PD-L1 in vivo, which is consistent with our previous in vitro research results (Fig. 6E). Here, SLC2A1 is linked to neoplasm.